Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
2.
Kardiologiia ; 53(11): 84-9, 2013.
Artigo em Russo | MEDLINE | ID: mdl-24654440

RESUMO

Contemporary approach to antianginal therapy in patients with stable are reviewed. Benefits and limitations of "standard" antiischemic therapy and evidence-based data about alternative therapy with nicorandil are discussed in details.


Assuntos
Doença da Artéria Coronariana/tratamento farmacológico , Nicorandil/uso terapêutico , Guias de Prática Clínica como Assunto , Vasodilatadores/uso terapêutico , Humanos , Resultado do Tratamento
9.
Ter Arkh ; 76(12): 32-6, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15724922

RESUMO

AIM: To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments. MATERIAL AND METHODS: Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003. RESULTS: Arterial hypertension, coronary heart disease were diagnosed in 93.2 and 87.2% examinees. History of myocardial infarction and brain stroke was in 8.4 and 6% patients. Statins were prescribed in 2.4% cases. Examination for dyslipidemia was not satisfactory. ACE inhibitors were prescribed in 71.2% patients. Aspirin was prescribed (18%) primarily by the cardiologist. CONCLUSION: Quality of medical prophylaxis of CVD RF in DM type 2 patients in the departments does not satisfy modern clinical recommendations.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/administração & dosagem , Aspirina/administração & dosagem , Doenças Cardiovasculares/prevenção & controle , Diabetes Mellitus Tipo 2 , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Inibidores da Agregação Plaquetária/administração & dosagem , Doenças Cardiovasculares/complicações , Diabetes Mellitus Tipo 2/complicações , Endocrinologia , Departamentos Hospitalares , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...